Fli1 Represses Transcription of the Human α2(I) Collagen Gene by Recruitment of the HDAC1/p300 Complex

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Asano, Yoshihide ^a   Trojanowska, Maria ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COLLAGEN; COLLAGEN ALPHA 2 I; E1A ASSOCIATED P300 PROTEIN; ENTINOSTAT; HISTONE DEACETYLASE 1; THREONINE; TRANSCRIPTION FACTOR FLI 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN ASSEMBLY AND DISASSEMBLY; COL1A2 GENE; COLLAGEN SYNTHESIS; COMPLEX FORMATION; CONTROLLED STUDY; DEACETYLATION; ENZYME ANALYSIS; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VIVO STUDY; NEWBORN; NORMAL HUMAN; PHARMACOLOGICAL BLOCKING; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKIN FIBROBLAST; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CELLS, CULTURED; COLLAGEN TYPE I; DERMIS; E1A-ASSOCIATED P300 PROTEIN; EPIGENESIS, GENETIC; FEMALE; FIBROBLASTS; HISTONE DEACETYLASE 1; HUMANS; MALE; MULTIPROTEIN COMPLEXES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEIN C-FLI-1; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884166152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074930     Document Type: Article

References (35)

1. Ben-David Y, Giddens EB, Bernstein A, (1990) Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci U S A 87: 1332-1336.
2. Ben-David Y, Giddens EB, Letwin K, Bernstein A, (1991) Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev 5: 908-918.
3. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162-165.
4. Hollenhorst PC, Jones DA, Graves BJ, (2004) Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32: 5693-5702.
5. Tamaki T, Ohnishi K, Hartl C, LeRoy EC, Trojanowska M, (1995) Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the α2(I) collagen gene in human fibroblasts. J Biol Chem 270: 4299-4304.
6. Mager AM, Grapin-Botton A, Ladjali K, Meyer D, Wolff CM, et al. (1998) The avian fli gene is specifically expressed during embryogenesis in a subset of neural crest cells giving rise to mesenchyme. Int J Dev Biol 42: 561-572.
7. Masuya M, Moussa O, Abe T, Deguchi T, Higuchi T, et al. (2005) Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Blood 105: 95-102.
8. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, et al. (2000) Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 20: 5643-5652.
9. Asano Y, Stawski L, Hant F, Highland K, Silver R, et al. (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176: 1983-1998.
10. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M, (2001) Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276: 20839-20848.
11. Jinnin M, Ihn H, Yamane K, Mimura Y, Asano Y, et al. (2005) α2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res 33: 1337-1351.
12. Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, et al. (2003) Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163: 571-581.
13. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, et al. (2006) Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol 206: 718-727.
14. Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M, (1999) Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18: 7755-7764.
15. Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, et al. (2005) Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 33: 3540-3549.
16. Noda S, Asano Y, Akamata K, Aozasa N, Taniguchi T, et al. (2012) A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis. PLoS One 7: e32272.
17. Noda S, Asano Y, Takahashi T, Akamata K, Aozasa N, et al. (2013) Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis. Rheumatology (Oxford). [Epub ahead of print] PubMed PMID: 23287360.
18. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M, (2006) Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 281: 25259-25269.
19. Noda S, Asano Y, Akamata K, Aozasa N, Taniguchi T, et al. (2012) Constitutive activation of c-Abl/protein kinase C-δ/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma. Br J Dermatol 167: 1098-1105.
20. Asano Y, Czuwara J, Trojanowska M, (2007) Transforming growth factor-β regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. J Biol Chem 282: 34672-34683.
21. Asano Y, Trojanowska M, (2009) Phosphorylation of Fli1 at threonine 312 by protein kinase C δ promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor β. Mol Cell Biol 29: 1882-1894.
22. Bujor AM, Asano Y, Haines P, Lafyatis R, Trojanowska M, (2011) The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts. Arthritis Rheum 63: 1729-1737.
23. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M, (2006) Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 281: 25259-25269.
24. Fournel M, Bonfils C, Hou Y, Yan PT, Trachy-Bourget MC, et al. (2008) MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo. Mol Cancer Ther 7: 759-768.
25. Baran CP, Fischer SN, Nuovo GJ, Kabbout MN, Hitchcock CL,et al. The transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol. 45: 999-1006.
26. Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M, (2002) Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β. J Biol Chem 277: 20399-20408.
27. Koinuma D, Tsutsumi S, Kamimura N, Taniguchi H, Miyazawa K, et al. (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling. Mol Cell Biol 29: 172-186.
28. Ghosh AK, Varga J, (2007) The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol 213: 663-671.
29. Simone C, Stiegler P, Forcales SV, Bagella L, De Luca A, et al. (2004) Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300. Oncogene 23: 2177-2187.
30. Li B, Samanta A, Song X, Iacono KT, Bembas K, et al. (2007) FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci U S A 104: 4571-4576.
31. Yamagoe S, Kanno T, Kanno Y, Sasaki S, Siegel RM, et al. (2003) Interaction of histone acetylases and deacetylases in vivo. Mol Cell Biol 23: 1025-1033.
32. Peserico A, Simone C, (2011) Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol 2011: 371832.
33. Pang M, Zhuang S, (2010) Histone deacetylase: a potential therapeutic target for fibrotic disorders. J Pharmacol Exp Ther 335: 266-272.
34. Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, et al. (2007) Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum 56: 2755-2764.
35. Hemmatazad H, Rodrigues HM, Maurer B, Brentano F, Pileckyte M, et al. (2009) Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis Rheum 60: 1519-1529.